Ftse Mib
34.129,11
-0,33%
DAX
18.514,28
0,41%
S&P 500
5.187,70
0,13%
NASDAQ
16.332,56
-0,10%
Bitcoin
62.336,25
0,00%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tevogen Bio Holdings Inc (TVGN) Tevogen Bio Holdings Inc (TVGN) Notizie

Tevogen Bio Holdings Inc

TVGN
0,9905
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 10:05:17
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202414:05GLOBETevogen Bio Announces Full Year 2023 Financial Results and..
26/4/202415:23GLOBETevogen Bio CEO Highlights Expected Reporting of a $94.9..
11/4/202414:05GLOBETevogen Bio’s Chief Scientific Officer Speaks on the..
03/4/202414:05GLOBETevogen Bio Appoints Tapan V Shah as Head of Investor..
28/3/202413:05GLOBETevogen Bio Reports Series A-1 Preferred Stock Investment at..
20/3/202412:00BWTevogen Bio Reports Its Investigational SARS-CoV-2 Specific..
05/3/202414:00BWTevogen Bio Holdings Congratulates its Board Member and..
04/3/202422:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/2/202422:39BWMittul Mehta, Head of Tevogen's Artificial Intelligence..
23/2/202402:13EDGAR2Form SC 13D - General statement of acquisition of beneficial..
23/2/202402:09EDGAR2Form SC 13D - General statement of acquisition of beneficial..
21/2/202422:30EDGAR2Form 8-K - Current report
21/2/202413:00BWCell Therapy Company Tevogen Bio Holdings Inc. Prepares to..
20/2/202414:57EDGAR2Form 8-K/A - Current report: [Amend]
17/2/202406:17BWCell Therapy Company Tevogen Bio Holdings Inc. (Nasdaq:..
16/2/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202423:20EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:19EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:17EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:14EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202423:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
Apertura: Min: Max:
Chiusura: 0,9905

La tua Cronologia

NASDAQ
TVGN
Tevogen Bio
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network